APOE and Alzheimer disease: Deletion of either receptor increases amyloid deposition but apoE binding to other receptors such as VLDLR and apoER2 could serve to activate protective signaling, as shown with ligands such as reelin-COLBOS that protects against AD pathology by over-activating the Dab1 signaling pathway [197, 226, 227].